News Â鶹´«Ã½ from University of Maryland School of Medicine display Latest news from University of Maryland School of Medicine on News en-us Copyright 2024 News News Â鶹´«Ã½ from University of Maryland School of Medicine 115 31 / /images/newswise-logo-rss.gif UM School of Medicine Researchers Link Snoring to Behavioral Problems in Adolescents without Declines in Cognition /articles/um-school-of-medicine-researchers-link-snoring-to-behavioral-problems-in-adolescents-without-declines-in-cognition/?sc=rsin /articles/um-school-of-medicine-researchers-link-snoring-to-behavioral-problems-in-adolescents-without-declines-in-cognition/?sc=rsin Thu, 21 Nov 2024 15:50:41 EST Adolescents who snore frequently were more likely to exhibit behavior problems such as inattention, rule-breaking, and aggression, but they do not have any decline in their cognitive abilities, according to a new study conducted by researchers at the University of Maryland School of Medicine (UMSOM). University of Maryland School of Medicine Exposure to Marijuana in the Womb May Increase Risk of Addiction to Opioids Later in Life, Study Finds /articles/exposure-to-marijuana-in-the-womb-may-increase-risk-of-addiction-to-opioids-later-in-life-study-finds/?sc=rsin /articles/exposure-to-marijuana-in-the-womb-may-increase-risk-of-addiction-to-opioids-later-in-life-study-finds/?sc=rsin Wed, 13 Nov 2024 17:00:56 EST University of Maryland School of Medicine Researchers Identify Neurobiological Changes Leading to Increase Release of the Brain Chemical Dopamine and Its Target Neurons Linked to Addiction-Like Behavior With the increased legalization of recreational cannabis, as many as 1 in 5 pregnant women in the U.S. are now using the drug to help with morning sickness, lower back pain or anxiety. University of Maryland School of Medicine Genomic Databases Need More Diversity /articles/genomic-databases-need-more-diversity/?sc=rsin /articles/genomic-databases-need-more-diversity/?sc=rsin Thu, 31 Oct 2024 11:00:00 EST Researchers at the Institute for Genome Sciences (IGS) at the University of Maryland School of Medicine (UMSOM) have developed a broad and deep genomic database of Latin Americans which gathers genome-wide data of Latin American populations into a single source and allows other scientists to easily add that population to their own research studies without straining budgets. University of Maryland School of Medicine UM School of Medicine's Margaret M. McCarthy, PhD, Elected as Member of Prestigious National Academy of Medicine /articles/um-school-of-medicine-s-margaret-m-mccarthy-phd-elected-as-member-of-prestigious-national-academy-of-medicine/?sc=rsin /articles/um-school-of-medicine-s-margaret-m-mccarthy-phd-elected-as-member-of-prestigious-national-academy-of-medicine/?sc=rsin Wed, 23 Oct 2024 13:00:24 EST Margaret M. McCarthy, PhD, an internationally-recognized neuroscientist, who is the James and Carolyn Frenkil Dean's Endowed Professor in the University of Maryland School of Medicine's Department of Pharmacology, Physiology, and Drug Development, and Director of the University of Maryland - Medicine Institute of Neuroscience Discovery (UM-MIND), has been elected as a new member of the National Academy of Medicine. University of Maryland School of Medicine UMSOM Launches New Rural Health Initiative to Address Physician Shortage on Maryland's Eastern Shore /articles/umsom-launches-new-rural-health-initiative-to-address-physician-shortage-on-maryland-s-eastern-shore/?sc=rsin /articles/umsom-launches-new-rural-health-initiative-to-address-physician-shortage-on-maryland-s-eastern-shore/?sc=rsin Wed, 09 Oct 2024 12:05:48 EST With a commitment to addressing rural health disparities and the challenges faced by Maryland's rural Eastern Shore residents, the University of Maryland School of Medicine has launched the Rural Health Equity and Access Longitudinal Elective (R-HEALE). University of Maryland School of Medicine UM School of Medicine Establishes Three New Endowed Professorships through Maryland E-Nnovation Awards and UMB Matching Funds /articles/um-school-of-medicine-establishes-three-new-endowed-professorships-through-maryland-e-nnovation-awards-and-umb-matching-funds/?sc=rsin /articles/um-school-of-medicine-establishes-three-new-endowed-professorships-through-maryland-e-nnovation-awards-and-umb-matching-funds/?sc=rsin Wed, 18 Sep 2024 12:05:00 EST University of Maryland School of Medicine (UMSOM) Dean Mark T. Gladwin, announced today that the School of Medicine has been awarded $2 million in matching funds from the Maryland E-Nnovation Initiative Fund (MEIF), administered by the Maryland Department of Commerce. The funds, totaling $4 million when combined with UMB qualified funding, will enable the establishment of three endowed research professorships. University of Maryland School of Medicine UM School of Medicine Aims to Accelerate Basic Science Research and Advance Drug Therapies with Newly-Created Department /articles/um-school-of-medicine-aims-to-accelerate-basic-science-research-and-advance-drug-therapies-with-newly-created-department/?sc=rsin /articles/um-school-of-medicine-aims-to-accelerate-basic-science-research-and-advance-drug-therapies-with-newly-created-department/?sc=rsin Tue, 17 Sep 2024 14:05:28 EST University of Maryland School of Medicine (UMSOM) Dean Mark T. Gladwin, MD, has announced the formation of a new Department of Pharmacology, Physiology and Drug Development, which merges the Department of Physiology and Department of Pharmacology. This new Department aligns the basic science research efforts of both entities with a strong emphasis on the development of new drug therapies. University of Maryland School of Medicine Leading Computational Scientist and Oncology Researcher Elana Fertig, PhD, Appointed as New Director of the Institute for Genome Sciences at the University of Maryland School of Medicine /articles/leading-computational-scientist-and-oncology-researcher-elana-fertig-phd-appointed-as-new-director-of-the-institute-for-genome-sciences-at-the-university-of-maryland-school-of-medicine/?sc=rsin /articles/leading-computational-scientist-and-oncology-researcher-elana-fertig-phd-appointed-as-new-director-of-the-institute-for-genome-sciences-at-the-university-of-maryland-school-of-medicine/?sc=rsin Wed, 28 Aug 2024 12:05:53 EST University of Maryland School of Medicine (UMSOM) Dean Mark T. Gladwin, MD, announced today the appointment of Elana J. Fertig, PhD, FAIMBE, as the new Director of the School's Institute for Genome Sciences (IGS). University of Maryland School of Medicine Nationally Recognized Behavioral Scientist Dr. Kelly Dunn Named Director of the Kahlert Institute for Addiction Medicine at the University of Maryland School of Medicine /articles/nationally-recognized-behavioral-scientist-dr-kelly-dunn-named-director-of-the-kahlert-institute-for-addiction-medicine-at-the-university-of-maryland-school-of-medicine/?sc=rsin /articles/nationally-recognized-behavioral-scientist-dr-kelly-dunn-named-director-of-the-kahlert-institute-for-addiction-medicine-at-the-university-of-maryland-school-of-medicine/?sc=rsin Mon, 19 Aug 2024 13:05:53 EST University of Maryland School of Medicine (UMSOM) Dean Mark T. Gladwin, MD, announced today the appointment of Kelly Dunn, PhD, MBA, one of the nation's leading researchers on opioid use disorder, as the inaugural Director of the School's Kahlert Institute for Addiction Medicine University of Maryland School of Medicine Study: Living in Disadvantaged Neighborhoods Influences Stress-Related Genes, Which May Contribute to Aggressive Prostate Cancer in African American Men /articles/study-living-in-disadvantaged-neighborhoods-influences-stress-related-genes-which-may-contribute-to-aggressive-prostate-cancer-in-african-american-men/?sc=rsin /articles/study-living-in-disadvantaged-neighborhoods-influences-stress-related-genes-which-may-contribute-to-aggressive-prostate-cancer-in-african-american-men/?sc=rsin Thu, 15 Aug 2024 16:05:21 EST Study: Living in Disadvantaged Neighborhoods Influences Stress-Related Genes, Which May Contribute to Aggressive Prostate Cancer in African American Men University of Maryland School of Medicine Patients with Unexplainable Chronic Itch Have Unique Blood Biomarkers that Could Eventually Lead to New Targeted Treatments /articles/patients-with-unexplainable-chronic-itch-have-unique-blood-biomarkers-that-could-eventually-lead-to-new-targeted-treatments/?sc=rsin /articles/patients-with-unexplainable-chronic-itch-have-unique-blood-biomarkers-that-could-eventually-lead-to-new-targeted-treatments/?sc=rsin Wed, 14 Aug 2024 14:05:34 EST Millions of patients worldwide suffer from a chronic itching condition with no identifiable cause - a condition known as chronic pruritus of unknown origin (CPUO) - that has no targeted therapies approved to treat it. Many of these patients suffer for years with little relief, but a new University of Maryland School of Medicine study may provide hope for future treatments. Patients were found to have lower than normal levels of metabolite biomarkers in the blood plasma that could point to a cause of their excruciating symptoms. University of Maryland School of Medicine Orthopaedic Surgeon-Scientist Dr. Frank Henn Named Chair of the Department of Orthopaedics /articles/orthopaedic-surgeon-scientist-dr-frank-henn-named-chair-of-the-department-of-orthopaedics/?sc=rsin /articles/orthopaedic-surgeon-scientist-dr-frank-henn-named-chair-of-the-department-of-orthopaedics/?sc=rsin Mon, 29 Jul 2024 13:05:17 EST Dr. Henn is Established Academic Leader with Strong Track Record of Success in Research and Clinical Care; Led Department's Residency Program to Become Among Top in the Nation University of Maryland School of Medicine Faculty Physicians to Establish New Community "Health Village" at Mondawmin Mall /articles/faculty-physicians-to-establish-new-community-health-village-at-mondawmin-mall/?sc=rsin /articles/faculty-physicians-to-establish-new-community-health-village-at-mondawmin-mall/?sc=rsin Tue, 09 Jul 2024 22:05:40 EST New Leased Space Will Include Adult and Pediatric Primary Care, Mental Health Services, Prenatal Care, and Nutrition Counseling University of Maryland School of Medicine Drug Used to Treat Eczema May Provide Relief for Patients with Intensely Itchy Skin Diseases /articles/drug-used-to-treat-eczema-may-provide-relief-for-patients-with-intensely-itchy-skin-diseases/?sc=rsin /articles/drug-used-to-treat-eczema-may-provide-relief-for-patients-with-intensely-itchy-skin-diseases/?sc=rsin Wed, 05 Jun 2024 17:05:10 EST Clinical Trial Finds Oral Medication Significantly Reduced Prurigo Nodularis and Chronic Pruritus of Unknown Origin Symptoms A drug approved to treat eczema provided significant improvement in the symptoms of patients with severe itching diseases that currently have no targeted treatments, according to a new study published in JAMA Dermatology. University of Maryland School of Medicine University of Maryland School of Medicine Launches Vaccine Development Program to Prevent Sepsis in Newborns /articles/university-of-maryland-school-of-medicine-launches-vaccine-development-program-to-prevent-sepsis-in-newborns-newsarchive-pages2024-newsuniversity-of-maryland-school-of-medicine-launches-vaccine-development-program-to-prevent-sepsis-in-newborns/?sc=rsin /articles/university-of-maryland-school-of-medicine-launches-vaccine-development-program-to-prevent-sepsis-in-newborns-newsarchive-pages2024-newsuniversity-of-maryland-school-of-medicine-launches-vaccine-development-program-to-prevent-sepsis-in-newborns/?sc=rsin Tue, 21 May 2024 12:05:06 EST University of Maryland School of Medicine (UMSOM) researchers at the Center for Vaccine Development and Global Health (CVD) have been awarded $3.96 million to develop a maternal vaccine that prevents sepsis caused by Klebsiella pneumoniae in newborns and infants. University of Maryland School of Medicine Women Need Better Treatments for Bacterial Vaginosis /articles/women-need-better-treatments-for-bacterial-vaginosis/?sc=rsin /articles/women-need-better-treatments-for-bacterial-vaginosis/?sc=rsin Thu, 02 May 2024 11:00:00 EST Bacterial Vaginosis (BV) affects about one-quarter of reproductive-age women and is linked to adverse health outcomes, such as increased HIV risk. Yet for decades, BV treatment in the United States has largely relied on antibiotics, and BV recurrence is common following antibiotic therapy. University of Maryland School of Medicine UMSOM Preclinical Study Finds Novel Stem Cell Therapy Boosts Neural Repair After Cardiac Arrest /articles/umsom-preclinical-study-finds-novel-stem-cell-therapy-boosts-neural-repair-after-cardiac-arrest/?sc=rsin /articles/umsom-preclinical-study-finds-novel-stem-cell-therapy-boosts-neural-repair-after-cardiac-arrest/?sc=rsin Wed, 01 May 2024 11:05:46 EST New stem cell therapy in animal model could eventually lead to viable treatment option  Researchers at the University of Maryland School of Medicine (UMSOM) have identified an innovation in stem cell therapy to regenerate neural cells in the brain after cardiac arrest in an animal model.  University of Maryland School of Medicine University of Maryland Greenebaum Comprehensive Cancer Center and AstraZeneca Partner to Enhance Community-Based Lung Cancer Screening and Detection for Marylanders at High Risk /articles/university-of-maryland-greenebaum-comprehensive-cancer-center-and-astrazeneca-partner-to-enhance-community-based-lung-cancer-screening-and-detection-for-marylanders-at-high-risk/?sc=rsin /articles/university-of-maryland-greenebaum-comprehensive-cancer-center-and-astrazeneca-partner-to-enhance-community-based-lung-cancer-screening-and-detection-for-marylanders-at-high-risk/?sc=rsin Wed, 17 Apr 2024 13:05:04 EST With only a small percentage of Marylanders at high risk for lung cancer getting the recommended annual screening, the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center (UMGCCC) today launched a new statewide effort to increase annual screenings. University of Maryland School of Medicine Researchers Identify New Genetic Risk Factors for Persistent HPV Infections /articles/researchers-identify-new-genetic-risk-factors-for-persistent-hpv-infections22/?sc=rsin /articles/researchers-identify-new-genetic-risk-factors-for-persistent-hpv-infections22/?sc=rsin Thu, 11 Apr 2024 09:05:06 EST Human papillomavirus (HPV) is the second most common cancer-causing virus, accounting for 690,000 cervical and other cancers each year worldwide. University of Maryland School of Medicine UMSOM Researchers Identify Safety of a Potential New Treatment to Manage Complications from Sickle Cell Disease /articles/treatment-for-lung-condition-could-help-patients-with-sickle-cell-disease-control-complications-from-hypertension-and-kidney-damage/?sc=rsin /articles/treatment-for-lung-condition-could-help-patients-with-sickle-cell-disease-control-complications-from-hypertension-and-kidney-damage/?sc=rsin Thu, 11 Apr 2024 07:05:54 EST Treatment for lung condition could help patients with sickle cell disease control complications from hypertension and kidney damage University of Maryland School of Medicine